226 related articles for article (PubMed ID: 33435770)
21. Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with
Chen ZM; Yang XY; Li ZT; Guan WJ; Qiu Y; Li SQ; Zhan YQ; Lei ZY; Liu J; Zhang JQ; Wang ZF; Ye F
Infect Drug Resist; 2022; 15():3381-3393. PubMed ID: 35789796
[TBL] [Abstract][Full Text] [Related]
22. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.
Hong GH; Ortega-Villa AM; Hunsberger S; Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Rosen LB; Zerbe CS; Holland SM
Clin Infect Dis; 2020 Jun; 71(1):53-62. PubMed ID: 31429907
[TBL] [Abstract][Full Text] [Related]
23. Disseminated Coinfection by
Huang H; Deng J; Qin C; Zhou J; Duan M
Infect Drug Resist; 2021; 14():3619-3625. PubMed ID: 34526784
[TBL] [Abstract][Full Text] [Related]
24. Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report.
Poulin S; Corbeil C; Nguyen M; St-Denis A; Côté L; Le Deist F; Carignan A
BMC Infect Dis; 2013 Jan; 13():24. PubMed ID: 23336346
[TBL] [Abstract][Full Text] [Related]
25. Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated
Chetchotisakd P; Anunnatsiri S; Nanagara R; Nithichanon A; Lertmemongkolchai G
J Immunol Res; 2018; 2018():6473629. PubMed ID: 30687765
[TBL] [Abstract][Full Text] [Related]
26. Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies.
Li S; Cao X; Guo Z; Wang J; Tong J; Zhang Z
An Bras Dermatol; 2024; 99(2):233-237. PubMed ID: 37926601
[TBL] [Abstract][Full Text] [Related]
27. Brain Nocardiosis and Pulmonary Talaromycosis Infection in a Patient with Anti-IFN-γ Autoantibodies: A Case Report.
Wu S; Guo T; Zhang H; He Z; Zhang J; Zeng W
Infect Drug Resist; 2023; 16():5421-5425. PubMed ID: 37638063
[TBL] [Abstract][Full Text] [Related]
28. Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms.
Wipasa J; Chaiwarith R; Chawansuntati K; Praparattanapan J; Rattanathammethee K; Supparatpinyo K
Exp Biol Med (Maywood); 2018 Apr; 243(7):621-626. PubMed ID: 29512397
[TBL] [Abstract][Full Text] [Related]
29. Intravenous Cyclophosphamide Therapy for Anti-IFN-γ Autoantibody-Associated
Zeng W; Tang M; Yang M; Fang G; Tang S; Zhang J
Open Forum Infect Dis; 2022 Dec; 9(12):ofac612. PubMed ID: 36519123
[TBL] [Abstract][Full Text] [Related]
30.
Lin F; Yang Z; Qiu Y; Zeng W; Liu G; Zhang J
Infect Drug Resist; 2021; 14():5005-5013. PubMed ID: 34866920
[TBL] [Abstract][Full Text] [Related]
31. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
33. Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report.
Keragala BSDP; Gunasekera CN; Yesudian PD; Guruge C; Dissanayaka BS; Liyanagama DP; Jinadasa GIM; Constantine SR; Herath HMMTB
BMC Infect Dis; 2020 Apr; 20(1):258. PubMed ID: 32234012
[TBL] [Abstract][Full Text] [Related]
34. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
[TBL] [Abstract][Full Text] [Related]
35. Unusual disseminated Talaromyces marneffei infection mimicking lymphoma in a non-immunosuppressed patient in East China: a case report and review of the literature.
Chen D; Chang C; Chen M; Zhang Y; Zhao X; Zhang T; Wang Z; Yan J; Zhu H; Zheng L; Zhao K
BMC Infect Dis; 2020 Oct; 20(1):800. PubMed ID: 33115429
[TBL] [Abstract][Full Text] [Related]
36. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
[TBL] [Abstract][Full Text] [Related]
37. Sweet's Syndrome Associated with
Xu H; Liu D; He X; Zheng D; Deng Y
Indian J Dermatol; 2018; 63(5):428-430. PubMed ID: 30210169
[No Abstract] [Full Text] [Related]
38. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases.
Zeng Q; Jin Y; Yin G; Yang D; Li W; Shi T; Lu G; Huang L; Fan H
BMC Infect Dis; 2021 Mar; 21(1):287. PubMed ID: 33743629
[TBL] [Abstract][Full Text] [Related]
39. Talaromyces marneffei infection in a lung cancer patient: a rare case report.
Lin F; Qiu Y; Zeng W; Liang Y; Zhang J
BMC Infect Dis; 2019 Apr; 19(1):336. PubMed ID: 31014277
[TBL] [Abstract][Full Text] [Related]
40. Rare incidence of non-secretory myeloma with talaromycosis: a case report.
Qin H; Qiu Y; Huang Y; Pan M; Lan D; Zeng W; Zhang J
BMC Infect Dis; 2021 Sep; 21(1):964. PubMed ID: 34530743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
